The Sickle Cell Disease Treatment market is witnessing remarkable transformation, fueled by rapid advancements in biotechnology, increasing global disease burden, and strong investments in innovative therapies. The Sickle Cell Disease Treatment Market was valued at US$ 1,160.16 million in 2022 and is projected to reach US$ 4,691.87 million by 2030, expanding at a CAGR of 19.1% from 2022 to...